Search

Jennifer Castriotta

Examiner (ID: 2648, Phone: (571)270-5279 , Office: P/3781 )

Most Active Art Unit
3733
Art Unit(s)
3781, 3733
Total Applications
769
Issued Applications
457
Pending Applications
68
Abandoned Applications
260

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 11657512 [patent_doc_number] => 09670504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-06 [patent_title] => 'Transgenic system for reversibly immortalizing mammalian quiescent cells' [patent_app_type] => utility [patent_app_number] => 14/124184 [patent_app_country] => US [patent_app_date] => 2012-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9181 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124184 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/124184
Transgenic system for reversibly immortalizing mammalian quiescent cells Jul 5, 2012 Issued
Array ( [id] => 9254464 [patent_doc_number] => 08617876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'Rhodopsin gene conserved regions in a viral vector enhance expression' [patent_app_type] => utility [patent_app_number] => 13/539835 [patent_app_country] => US [patent_app_date] => 2012-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 21 [patent_no_of_words] => 36258 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 254 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13539835 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/539835
Rhodopsin gene conserved regions in a viral vector enhance expression Jul 1, 2012 Issued
Array ( [id] => 16406742 [patent_doc_number] => 10815285 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 14/126708 [patent_app_country] => US [patent_app_date] => 2012-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 14958 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126708 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/126708
Recombinant adeno-associated virus-mediated expression of fractalkine for treatment of neuroinflammatory and neurodegenerative diseases Jun 29, 2012 Issued
Array ( [id] => 8516818 [patent_doc_number] => 20120316226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR' [patent_app_type] => utility [patent_app_number] => 13/533322 [patent_app_country] => US [patent_app_date] => 2012-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17552 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13533322 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/533322
METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR Jun 25, 2012 Abandoned
Array ( [id] => 8502554 [patent_doc_number] => 20120301962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'VITRONECTIN-DERIVED CELL CULTURE SUBSTRATE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/464235 [patent_app_country] => US [patent_app_date] => 2012-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6444 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13464235 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/464235
Vitronectin-derived cell culture substrate and uses thereof May 3, 2012 Issued
Array ( [id] => 9308896 [patent_doc_number] => 20140047570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'ANIMAL MODEL OF HUMAN CANCER AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/113014 [patent_app_country] => US [patent_app_date] => 2012-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15454 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113014 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/113014
ANIMAL MODEL OF HUMAN CANCER AND METHODS OF USE Apr 18, 2012 Abandoned
Array ( [id] => 8768333 [patent_doc_number] => 20130096370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'COMPOSITIONS AND SYSTEMS FOR THE REGULATION OF GENES' [patent_app_type] => utility [patent_app_number] => 13/448580 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32232 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448580 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/448580
COMPOSITIONS AND SYSTEMS FOR THE REGULATION OF GENES Apr 16, 2012 Abandoned
Array ( [id] => 9148370 [patent_doc_number] => 20130302893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-14 [patent_title] => 'METHOD FOR INCREASING THE EFFICIENCY OF INDUCING PLURIPOTENT STEM CELLS' [patent_app_type] => utility [patent_app_number] => 13/808596 [patent_app_country] => US [patent_app_date] => 2012-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8283 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808596 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/808596
Method for increasing the efficiency of inducing pluripotent stem cells Mar 30, 2012 Issued
Array ( [id] => 9297430 [patent_doc_number] => 20140041064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING VIRULENCE FACTORS AND ANTI-FUNGAL AGENTS' [patent_app_type] => utility [patent_app_number] => 14/003349 [patent_app_country] => US [patent_app_date] => 2012-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17406 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003349 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/003349
COMPOSITIONS AND METHODS FOR IDENTIFYING VIRULENCE FACTORS AND ANTI-FUNGAL AGENTS Mar 6, 2012 Abandoned
Array ( [id] => 9421744 [patent_doc_number] => 20140106395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-17 [patent_title] => 'Hanging Droplet Plate' [patent_app_type] => utility [patent_app_number] => 14/002269 [patent_app_country] => US [patent_app_date] => 2012-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6071 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14002269 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/002269
Hanging droplet plate Mar 1, 2012 Issued
Array ( [id] => 9286505 [patent_doc_number] => 08642835 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'ADAM6 mice' [patent_app_type] => utility [patent_app_number] => 13/404075 [patent_app_country] => US [patent_app_date] => 2012-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 46923 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13404075 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/404075
ADAM6 mice Feb 23, 2012 Issued
Array ( [id] => 12946234 [patent_doc_number] => 09834788 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-05 [patent_title] => AAV -vectors for use in gene therapy of choroideremia [patent_app_type] => utility [patent_app_number] => 14/000836 [patent_app_country] => US [patent_app_date] => 2012-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8378 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000836 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/000836
AAV -vectors for use in gene therapy of choroideremia Feb 20, 2012 Issued
Array ( [id] => 9175108 [patent_doc_number] => 20130317093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'METHODS OF TREATING ALZHEIMER\'S DISEASE WITH APO A-1 MILANO' [patent_app_type] => utility [patent_app_number] => 13/983956 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9964 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983956 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/983956
METHODS OF TREATING ALZHEIMER'S DISEASE WITH APO A-1 MILANO Feb 8, 2012 Abandoned
Array ( [id] => 8212309 [patent_doc_number] => 20120130303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'RATE CONTROL DURING AF USING CELLULAR INTERVENTION TO MODULATE AV NODE' [patent_app_type] => utility [patent_app_number] => 13/359949 [patent_app_country] => US [patent_app_date] => 2012-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 4268 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20120130303.pdf [firstpage_image] =>[orig_patent_app_number] => 13359949 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/359949
RATE CONTROL DURING AF USING CELLULAR INTERVENTION TO MODULATE AV NODE Jan 26, 2012 Abandoned
Array ( [id] => 9280224 [patent_doc_number] => 20140030192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Functional Targeted Brain Endoskeletonization' [patent_app_type] => utility [patent_app_number] => 13/980842 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7846 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13980842 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/980842
Functional Targeted Brain Endoskeletonization Jan 25, 2012 Abandoned
Array ( [id] => 10143256 [patent_doc_number] => 09176063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Modified fluorescent protein' [patent_app_type] => utility [patent_app_number] => 13/884520 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 18 [patent_no_of_words] => 5277 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13884520 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/884520
Modified fluorescent protein Nov 9, 2011 Issued
Array ( [id] => 12485139 [patent_doc_number] => 09992981 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-12 [patent_title] => Optogenetic control of reward-related behaviors [patent_app_type] => utility [patent_app_number] => 13/882670 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 48 [patent_no_of_words] => 24249 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882670 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/882670
Optogenetic control of reward-related behaviors Nov 3, 2011 Issued
Array ( [id] => 9265208 [patent_doc_number] => 20130347137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'Stabilized Step Function Opsin Proteins and Methods of Using the Same' [patent_app_type] => utility [patent_app_number] => 13/882666 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 32188 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882666 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/882666
Stabilized step function opsin proteins and methods of using the same Nov 3, 2011 Issued
Array ( [id] => 8210017 [patent_doc_number] => 20120129224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'Method and apparatus for changing one type of cell into another type of cell' [patent_app_type] => utility [patent_app_number] => 13/288801 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10237 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129224.pdf [firstpage_image] =>[orig_patent_app_number] => 13288801 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/288801
Method and apparatus for changing one type of cell into another type of cell Nov 2, 2011 Abandoned
Array ( [id] => 8177213 [patent_doc_number] => 20120110683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/288158 [patent_app_country] => US [patent_app_date] => 2011-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9908 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20120110683.pdf [firstpage_image] =>[orig_patent_app_number] => 13288158 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/288158
NON-HUMAN ANIMAL MODEL OF MYOCARDIAL INFARCTION AND METHOD FOR CREATING THE SAME Nov 2, 2011 Abandoned
Menu